Annual Report

Overview

The report presents Starpharma's ESG framework through four pillars - Governance, Our People, Products & Patient Health, and Environment - alongside a standalone ESG Report released each year. For FY22, it highlights no breaches of the Code of Conduct, anti-bribery and whistleblowing policies, 50% women on the Board, and no WorkSafe notifiable incidents in five years. The report also records VIRALEZE launches in Vietnam and Italy and registration in over 30 countries. Consolidated revenue was 4,899 $'000.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2022
Period: 1 July 2021 – 30 June 2022
Publication date: 25 August 2022
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services